VitalFlo Company
%20.jpg)
VitalFlo is a digital health company focused on helping doctors keep their asthmatic patients out of the ER. We do this by remotely monitoring patient lung function and the air quality around them for potential asthma attack triggers, and leveraging this dataset to develop predictive health analytics and forecasts. VitalFlo is redefining the standard of care for asthma management by providing actionable recommendations to patients when they need it most: before they have an asthma attack.
Investors
Industry:
P4 Medicine
Technology:
Predictive Medicine
Funding Status:
Seed
Estimated Revenue:
Less than $1M
Investors Number:
6
Headquarters:
Others
Employee Number:
1-10
Investor Type:
For Profit
Total Funding:
$1.5M
Founded Date:
2017-04-28
Last Funding Type:
Grant